Effect of immunonutrition on postoperative infectious complications and survival after colon cancer surgery: long-term follow up of randomized clinical trial
In brief
Preoperative immunonutrition did not improve 5-year survival after colon cancer surgery
In follow-up of 161 patients, immunonutrition for 7 days before surgery did not improve 5-year disease-free survival (80% versus 86%) or overall survival (88% versus 90%). Patients with postoperative infections had lower 5-year overall survival (74% versus 92%), particularly those with advanced tumors, but the study shows an association, not that infections caused poorer outcomes.
- Journal
- BJS open (Q1)
- Published
- 4 September 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Jaram Lee, Hyeung-Min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
- PMID
- 42782000
- DOI
- 10.1093/bjsopen/zrag043
Why clinicians should know about it
- Picked for Gastroenterology (top studies of the week, 27 September 2026): Preoperative immunonutrition, no endoscopic relevance
Abstract
BACKGROUND: A previous randomized clinical trial (RCT) in patients undergoing elective colon cancer surgery showed that preoperative immunonutrition did not reduce short-term postoperative infectious complications. This study reports the long-term follow-up of that RCT, evaluating the impact of preoperative immunonutrition and the association of postoperative infectious complications with survival outcomes. METHODS: This secondary analysis used prospectively collected survival data from a prior RCT in which patients were randomized 1:1 to receive either preoperative immunonutrition plus a normal diet or a normal diet alone (control) for 7 days before surgery. The primary endpoints were disease-free survival (DFS) and overall survival (OS). Survival outcomes were analysed in relation to randomized treatment allocation and clinicopathological variables, including postoperative complications, using Kaplan-Meier methods and Cox proportional hazards models. RESULTS: A total of 161 patients were included, with 79 randomized to immunonutrition and 82 to control. The mean age was 65.3 years, and 65.8% were male, with similar baseline characteristics between groups. After a median follow-up of 57 months (range 4-65), preoperative immunonutrition did not affect 5-year DFS (80% versus 86% in controls; P = 0.474) or 5-year OS (88% versus 90%; P = 0.761). In contrast, postoperative infectious complications were associated with lower 5-year OS (74% versus 92%; P = 0.013) and showed a trend towards worse DFS (71% versus 86%; P = 0.065). On multivariable analysis, advanced T category and postoperative infectious complications remained independently associated with poorer DFS (HR 2.53; P = 0.041) and OS (HR 4.14; P = 0.007). The adverse prognostic effect of infectious complications was evident primarily in patients with advanced T category disease. CONCLUSION: Preoperative immunonutrition did not improve long-term survival after colon cancer surgery. Postoperative infectious complications were independently associated with worse long-term outcomes, providing prospective evidence that supports previous observational findings.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.